This combination strategy increases DNA damage and blocks the repair process ... activity of PARPis with other cancer drugs like gemcitabine, cetuximab-monoclonal antibody, and vascular endothe ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback